Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia

Acta Psychiatrica Scandinavica

Volumn 94, Issue 2, 1996, Pages 118-124

  Browne, S ^a   Roe, M ^a   Lane, A ^a   Gervin, M ^a   Morris, M ^a   Kinsella, A ^b   Larkin, C ^a   O'Callaghan, E ^a,c  

^a St John of God Hospitaller Services Ireland   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c Cluain Mhuire Family Centre   (Ireland)

Author keywords

Negative symptoms; Neuroleptics; Quality of life; Schizophrenia; Tardive dyskinesia

Indexed keywords

ADULT; AGED; ARTICLE; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL ENVIRONMENT; TARDIVE DYSKINESIA;

EID: 0029816392     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb09835.x     Document Type: Article

References (40)

1. SKANTZE K, MALM U, DENCKER S, MAY P, CORRIGAN P. Comparison of quality of life with standard of living in schizophrenic outpatients. Br J Psychiatry 1992: 161: 797-801.
2. PINKNEY AA, GERBER GJ, LAFAVE HG. Quality of life after psychiatric rehabilitation: the clients' perspective. Acta Psychiatr Scand 1991: 83: 86-91.
3. O'BOYLE C. The schedule for the evaluation of individual quality of life. Int J Ment Health 1994: 23: 3-23.
4. Editorial. Quality of life and clinical trials. Lancet 1995: 346: 1-2.
5. ATTIKISSON C, COOK J, KARNO M et al. Caring for people with severe mental disorders: clinical services research. Schizophr Bull 1992: 18: 561-626.
6. Editorial. Quality of life. Lancet 1991: 338: 350-351.
7. O'BOYLE C, MCGEE H, HICKEY A, O'MALLEY K, JOYCE C. Individual quality of life in patients undergoing hip replacement. Lancet 1992: 339: 1088-1091.
8. EVANS RW. Quality of life. Lancet 1991: 338: 636.
9. HARWOOD R, EBRAHIM S. Quality of life. Lancet 1991: 338: 637.
10. MELTZER HY. Dimensions of outcome with clozapine. Br J Psychiatry 1992: 160 (Suppl. 17): 46-53.
11. AWAD AG. Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Commun Psych 1992: 43: 262-265.
12. LEHMAN AF. The well-being of chronic mental patients; assessing their quality of life. Arch Gen Psychiatry 1983: 40: 369-373.
13. MELTZER HY, BURNETT S, BASTANI B, RAMIREZ LF. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Commun Psych 1990: 41: 892-897.
14. SHTASEL PL, GUR RE, GALLACHER F, HEIMBERG C, GUR R. Gender differences in the clinical expression of schizophrenia. Schizophr Res 1992: 7: 225-231.
15. AWAD AG, HOGAN TP. Subjective response to neuroleptics and the quality of life: implications for treatment outcome. Acta Psychiatr Scand 1994: 89 (Suppl. 380): 27-31.
16. HEINRICHS DW, HANLON ET, CARPENTER WT JR. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984: 10: 388-398.
17. HESLEGRAVE RJ, VORUGANTI LNP, AWAD AG. Neuropsychiatric correlates of quality of life in psychiatry in schizophrenia. Schizophr Res 1995: 12: 216-217.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd edn. Washington, DC: American Psychiatric Association, 1987.
19. ANDREASEN NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa: The University of Iowa, 1983.
20. ANDREASEN NC. The Scale for the assessment of Positive Symptoms (SAPS). Iowa City, Iowa: The University of Iowa, 1984.
21. ANDREASEN NC. Negative vs. positive schizophrenia; definition and validation. Arch Gen Psychiatry 1982: 39: 789-794.
22. GUY W. Early Clinical Drug Evaluation Unit (ECDEU) assessment manual for psychopharmacology. Washington, DC; US Department of Health, Education and Welfare, 1976: 534-537.
23. SCHOOLER NR, KANE JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982: 39: 486-487.
24. DAVIS JM. Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 1976: 33: 858-860.
25. BELLACK AS, MORRISON RL, WIXTED JT, MUESER KT. An analysis of social competence in schizophrenia. Br J Psychiatry 1990: 156: 809-818.
26. LEHMAN AF, POSTRADO LT, RACHUBA LT. Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual Life Res 1993: 2: 327-333.
27. MALM U, MAY P, DENCKER S. Evaluation of the quality of life of the schizophrenic outpatient: a checklist. Schizophr Bull 1981: 7: 477-484.
28. LEWINE RRJ. Schizophrenia: an amotivational syndrome in men. Can J Psychiatry 1985: 30: 316-318.
29. FLOR-HENRY P. Influence of gender in schizophrenia as related to other psychopathological syndromes. Schizophr Bull 1990: 16: 211-227.
30. MURRAY RM, O"CALLAGHAN E, CASTLE DJ, LEWIS SW. A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 1992: 18: 319-332.
31. KANE JM, SMITH JM. Tardive dyskinesia; prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 1982: 39: 473-482.
32. BARRON ET, MCCREADIE RG. One-year follow-up of tardive dyskinesia. Br J Psychiatry 1983: 143: 423-424.
33. O'CALLAGHAN E, LARKIN C, KINSELLA A, WADDINGTON JL. Obstetric complications, the putative familial-sporadic distinction and tardive dyskinesia. Br J Psychiatry 1990: 157: 578-585.
34. GARDOS G, CASEY DE. Tardive dyskinesia and affective disorders. Washington, DC: American Psychiatric Association, 1984.
35. SMITH JM, BALDESSARINI RJ. Changes in prevalence, severity and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 1980: 37: 1368-1374.
36. WADDINGTON JL, YOUSSEF HA. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms. Am J Psychiatry 1986: 143: 1162-1165.
37. WADDINGTON JL, YOUSSEF HA, DOLPHIN C, KINSELLA A. Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia. Am J Psychiatry 1987: 44: 907-912.
38. BROWN KW, WHITE T. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia. Am J Psychiatry 1992: 149: 1385-1389.
39. CASEY DE. Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacol Bull 1989: 99: S47-S53.
40. LIEBERMAN J, JOHNS C, COOPER T. Clozapine pharmacology and tardive dyskinesia. Psychopharmacology 1989: 99: S54-S59.